Survival after blood transfusion

BACKGROUND: Long‐term survival of transfusion recipients has rarely been studied. This study examines short‐ and long‐term mortality among transfusion recipients and reports these as absolute rates and rates relative to the general population.

[1]  R. Szulkin,et al.  Statistical analysis of donation–transfusion data with complex correlation , 2007, Statistics in medicine.

[2]  M Reilly,et al.  A population‐based binational register for monitoring long‐term outcome and possible disease concordance among blood donors and recipients , 2006, Vox sanguinis.

[3]  P. Mortensen,et al.  The Danish Civil Registration System. A cohort of eight million persons. , 2006, Danish medical bulletin.

[4]  S. Goldie,et al.  Cost-Effectiveness of Alternative Blood-Screening Strategies for West Nile Virus in the United States , 2006, PLoS medicine.

[5]  B. Custer,et al.  The Cost-Effectiveness of Screening the U.S. Blood Supply for West Nile Virus , 2005, Annals of Internal Medicine.

[6]  S. Montgomery,et al.  Diagnosis and procedure‐specific survival among transfusion of recipients in 1993 and 2000, Örebro County, Sweden , 2005, Vox sanguinis.

[7]  A. Meyer,et al.  Blood transfusion is an independent predictor of increased mortality in nonoperatively managed blunt hepatic and splenic injuries. , 2005, The Journal of trauma.

[8]  C. Chapman,et al.  Long‐term survival after blood transfusion: a population based study in the North of England , 2004, Transfusion.

[9]  S. Kleinman,et al.  Survival after transfusion as assessed in a large multistate US cohort , 2004, Transfusion.

[10]  J. Wong,et al.  Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States , 2004, Vox sanguinis.

[11]  A. Valleron,et al.  Estimation of Epidemic Size and Incubation Time Based on Age Characteristics of vCJD in the United Kingdom , 2001, Science.

[12]  K. Juel.  [Impact of tobacco, alcohol overconsumption and drug abuse on mortality in Denmark. Trends over 25 years, 1973-1997]. , 2001, Ugeskrift for læger.

[13]  A. Shanwell,et al.  Long‐term survival in transfusion recipients in Sweden, 1993 , 2001, Transfusion.

[14]  K. Titlestad,et al.  Monitoring transfusion practices at two university hospitals , 2001, Vox sanguinis.

[15]  K. Juel,et al.  The Danish registers of causes of death. , 1999, Danish medical bulletin.

[16]  T. F. Andersen,et al.  The Danish National Hospital Register. A valuable source of data for modern health sciences. , 1999, Danish medical bulletin.

[17]  J. Blomberg,et al.  Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis , 1998, BMJ.

[18]  J. Birkmeyer,et al.  Value and cost‐effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window‐phase human immunodeficiency virus type 1 infections , 1997, Transfusion.

[19]  J. Birkmeyer,et al.  Cost‐effectiveness of expanded human immunodeficiency virus‐testing protocols for donated blood , 1997, Transfusion.

[20]  Johan Calltorp,et al.  Health care with equity and cost containment , 1996, The Lancet.

[21]  A. Giovanetti,et al.  Use of blood products for elective surgery in 43 European hospitals , 1994, Transfusion medicine.

[22]  E. Vamvakas,et al.  Long‐term survival after blood transfusion , 1994, Transfusion.

[23]  G. Whyte,et al.  The Transfused Population of Canterbury, New Zealand, and Its Mortality , 1988, Vox sanguinis.

[24]  International classification of diseases. WHO Collaborating Centers. , 1998, Epidemiological bulletin.

[25]  J Giesecke,et al.  Country profile: Sweden. , 1996, Lancet.

[26]  P I Terasaki,et al.  Long-term survival. , 1988, Clinical transplants.